PEARL (Post-market European & Asian Registry with Low-profile Minos™ Abdominal Aortic Stent Graft ) is a post-market open-ended global registry to assess clinical outcomes of the Minos™ Stent-Graft and Delivery System for endovascular repair of abdominal aortic pathology in a real-world population. All patients in this study are already planned to be treated with Minos™ and this study is designed to capture outcomes in a formalised system.
The CE approved Minos™ features a tri-modular design, allowing customised patient planning. Universal use of limbs on both sides, permits precise landing in short common iliacs, with added adjustable overlapping ability. Multiple clinical centres around the world will be involved to include a broad range of experience in a wide geographical span.
Enrolment will be of eligible patients undergoing treatment with the Minos™ system at each site, and all subjects will be followed procedurally to discharge and according to institutional standard of care to 5 years’ post implant.
It is intended that studying a real-world patient population in a multi-centre setting will provide an assessment of the generalisability of both approach and system.
About PEARL
About PEARL
About PEARL
PEARL (Post-market European & Asian Registry with Low-profile Minos™ Abdominal Aortic Stent Graft ) is a post-market open-ended global registry to assess clinical outcomes of the Minos™ Stent-Graft and Delivery System for endovascular repair of abdominal aortic pathology in a real-world population. All patients in this study are already planned to be treated with Minos™ and this study is designed to capture outcomes in a formalised system.
The CE approved Minos™ features a tri-modular design, allowing customised patient planning. Universal use of limbs on both sides, permits precise landing in short common iliacs, with added adjustable overlapping ability. Multiple clinical centres around the world will be involved to include a broad range of experience in a wide geographical span.
Enrolment will be of eligible patients undergoing treatment with the Minos™ system at each site, and all subjects will be followed procedurally to discharge and according to institutional standard of care to 5 years’ post implant.
It is intended that studying a real-world patient population in a multi-centre setting will provide an assessment of the generalisability of both approach and system.